Kestra Medical Technologies, Ltd. (KMTS) income statement
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.29+0.02 (+0.07%)
Close on Nov 18, 2026Market cap $1.69BP/E –Yield –
Kestra Medical Technologies, Ltd. income statement
Ratios
Latest available, balances at Jul 31, 2026
Profitability, TTM
- Gross margin
- 53.9%
- Operating margin
- -134.5%
- Net margin
- -140.4%
- Return on equity, FY2026
- –
Financial strength
- Current ratio
- 4.69
- Debt to equity
- –
- Debt to assets
- 20.9%
- Cash to current liabilities
- 142.0%
Valuation
- P/E ratio
- –
- Price to sales
- 15.79
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?